__timestamp | Lantheus Holdings, Inc. | Merus N.V. |
---|---|---|
Wednesday, January 1, 2014 | 72429000 | 3852327 |
Thursday, January 1, 2015 | 78634000 | 839656 |
Friday, January 1, 2016 | 75374000 | 4478145 |
Sunday, January 1, 2017 | 92157000 | 16432324 |
Monday, January 1, 2018 | 93326000 | 11890871 |
Tuesday, January 1, 2019 | 103132000 | 34110000 |
Wednesday, January 1, 2020 | 110171000 | 35781000 |
Friday, January 1, 2021 | 218817000 | 40896000 |
Saturday, January 1, 2022 | 233827000 | 52200000 |
Sunday, January 1, 2023 | 267194000 | 59836000 |
Cracking the code
In the ever-evolving landscape of corporate finance, understanding cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Lantheus Holdings, Inc. and Merus N.V. from 2014 to 2023. Over this period, Lantheus Holdings, Inc. has seen a significant increase in SG&A expenses, growing by approximately 270% from 2014 to 2023. This upward trend reflects strategic investments in operations and marketing. In contrast, Merus N.V. experienced a more modest increase of around 1,450% in the same period, indicating a different growth trajectory.
These insights provide a window into the financial strategies of these companies, offering valuable lessons in cost management and growth.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Comparing SG&A Expenses: Merck & Co., Inc. vs Merus N.V. Trends and Insights
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Merus N.V.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Incyte Corporation and Merus N.V.
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Merus N.V. Trends and Insights
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Merus N.V. vs Ligand Pharmaceuticals Incorporated